About Us

Curenetics unites a diverse team of leading experts dedicated to transforming cancer care

Curenetics is an AI driven precision oncology company transforming how cancer treatments are discovered, developed, and selected.

Our Cure-IO platform aggregates and analyses complex patient data including genomics, medical imaging, and clinical records from hospitals and laboratories to build advanced AI models that integrate multiple biomarkers. This multi modal approach delivers unprecedented predictive accuracy, helping identify which patients are most likely to benefit from specific therapies.

Currently at the Proof of Concept stage, Cure-IO is designed to integrate seamlessly with existing clinical and research workflows. For clinicians, it provides a reliable and cost effective tool to support treatment decisions. For pharmaceutical companies and CROs, it enables improved patient stratification, stronger trial design, and deeper biological insight across the drug development lifecycle.